Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Licenses Orchid s SNP-IT Tech

NEW YORK, Jan. 31 - Beckman Coulter has secured a nonexclusive license to Orchid BioSciences' SNP primer-extension system, the two companies said on Thursday.

 

Under the terms of the agreement, Beckman Coulter can incorporate Orchid's SNP-IT scoring technique into reagent kits, software, and SNP scoring products for international distribution. This technology can be adapted to DNA sequencer, microarray plates, or flow cytometers.

 

As part of the deal, Orchid will get an upfront payment, as well as royalties on sales of consumable products. Other financial details were not disclosed.

 

As part of a separate arrangement, Orchid acquired all rights to a Beckman patent for solid-phase sequencing through progressive primer extension, a technique that can be used to identify more than one SNP on a DNA sample.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.